Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
Closed Posted
- Opportunity number
- PAR-23-084
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
-
- 93.855 Allergy and Infectious Diseases Research
- 93.866 Aging Research
- Funding instrument
- Grant
- Category
-
- Health
- Eligible applicants
-
- Higher Education Inst. (Private)
- City/Township Governments
- Other
- Small Businesses
- Higher Education Inst. (Public)
- For Profit Organizations
- 501(c)(3) Nonprofits
- Tribal Governments (Federally Recognized)
- County Governments
- Independent School Districts
- Special District Governments
- State Governments
- Non-501(c)(3) Nonprofits
- Tribal Organizations (Not Federally Recognized)
- Public or Indian Housing Auth.
- Points of contact
-
- NIH OER Webmaster grantsinfo@nih.gov
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
This Funding Opportunity Announcement (FOA) from the National Institutes of Health (NIH) seeks applications for the implementation of investigator-initiated clinical trials requiring an extended project period of 6 or 7 years. The trials can be any phase, must be hypothesis-driven, and related to the research mission of the participating NIH Institute or Center. Consultation with NIH staff is strongly encouraged prior to submission. The FOA is not intended for support of clinical trials that do not require an extended project period. The key evaluation criteria include the trial's scientific merit, feasibility, and potential to advance the research mission. The application deadline is May 23, 2025.
The funding for this opportunity comes from the NIH's Allergy and Infectious Diseases Research program (CFDA 93.855) and Aging Research program (CFDA 93.866). The total funding amount and number of awards are not specified, but past awards under these programs have ranged from approximately $32,000 to over $1 million, typically lasting 2-5 years. The research is expected to be conducted at the recipient institutions across the United States.
Synopsis
This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated clinical trials requiring an extended project period of 6 or 7 years. The trials can be any phase, must be hypothesis-driven, and related to the research mission of the participating IC. Consultation with IC staff is strongly encouraged prior to the submission of the clinical trial implementation application. This FOA is not intended for support of clinical trials that do not require an extended project period of 6 or 7 years.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity